Enzymatically synthesized RNA samples (in vitro transcripts) were analysed by matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS). Spectra of RNA up to 150 kDA (461 nucleotides) are shown. Polymerase generated sample heterogeneity and its contribution to mass resolution are discussed. A time course exonuclease digest of a 55 nt in vitro transcript was analyzed to investigate the performance of MALDI-MS on complex mixtures. Based on these data, the analysis by MALDI-MS of DNA sequencing reactions, produced by the action of an RNA polymerase, is discussed.
INTRODUCTION
The analysis of nucleic acids by matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) is a new area of research. The technique bears several interesting practical applications as e.g. the verification of synthesis of modified oligonucleotides (1) , characterization of naturally occuring modified nucleic acids and sequencing of DNA as well as RNA. Most of the published work has been performed on synthetic oligodeoxynucleotides (2-6) (i.e. single stranded DNA) and signals from analytes up to 100 nucleotides (nt), approx. 35 kDa, have been reported (7) . However, the mass resolution for this type of molecules decreases dramatically with increasing size, mainly due to ion fragmentation. The most prominent type of fragmentation is the loss of purine bases and to a lesser extent also of cytosin from the deoxyribosephosphate backbone (8 -10) .
We have previously reported infrared (IR)-MALDI-MS analyses of chemically synthesized RNA (9) , which clearly exibit less fragmentation and better sensitivity than oligodeoxynucleotides. The reduced fragmentation can most likely be attributed to the 2'-OH group of the ribose ring which stabilises the N-glycosidic bond (11, 12) and prevents 1,2-trans-elimination of the nucleobases. In that study, however, spectra of in vitro transcripts displayed peaks with a mass resolution significantly below the instrumental limits. In order to investigate the cause of this reduced mass resolution, parallel analyses by ultraviolet (UV)-MALDI-MS and by denaturating polyacrylamide gels of a series of RNA species has been performed. We give a thorough description of the 5'-and 3'-heterogeneities and their contribution to mass resolution of in vitro transcripts in MALDI-MS. To demonstrate the performance of the method on complex mixtures, UV-MALDI-MS analysis of a time course exonuclease degraded in vitro transcript is also shown.
EXPERIMENTAL

Instrumentation
The MALDI-mass spectrometer used is a laboratory built instrument (8) . The system is equipped with a Q-switched frequency-tripled Nd:YAG laser (J.K.Lasers, System 2000) emitting laser pulses at the wavelength 355 nm with a pulse duration of 7 ns for the sample irradiation. The laser beam is focused onto the sample surface under 45° to a spot diameter of ca. 100 iim. The generated ions are accelerated to a total kinetic energy of 12 keV and are detected by a secondary electron multiplier (EMI 9643) equipped with a separately mounted dynode for a variable postacceleration. An instrumental mass resolution at up to 1000 (m/Am, Am: full width at the half maximum (FWHM) of the peak) can be obtained with this instrument for ions below ca. 10,000-12,000 Da under optimal conditions. Above 15,000 Da a high post acceleration (10-15 kV) of the analyte ions is required to improve the detection efficiency. The increased post acceleration combined with effects in the ion source lead to a reduced mass resolution of typically 100-200 (FWHM). The applied laser irradiance is usually varied between 10 6 and 10 7 W/cm 2 and the analog detector signal is digitized by a transient recorder (LeCroy 9400) at time intervals *To whom correspondence should be addressed of 10 or 20 ns; further data processing is done on a PC-AT using in-house developed software. Generally, single shot spectra clearly show the molecular-ion signals. To improve the signalto-noise ratio, 10 to 20 single shot spectra were usually accumulated and averaged. All spectra were calibrated externally using synthetic oligodeoxynucleotides as standards (9) . The analyte ions are detected predominantly as the singly protonated species.
Matrix preparation
The 3-hydroxypicolinic acid (3-HPA) matrix was purified by a separate desalting step before use. Alkali ions were exchanged with NH 4 + on an ammonium acetate (analytical grade, saturated solution) loaded cation exchange column (cation exchange polymer: BioRad, 50W-X8, mesh size 100-200 jun). After lyophilizing overnight, the 3-HPA was dissolved in ultra pure water to a concentration of ca. 300 mM, aliquoted in 50 /tl portions and stored at -20°C. To reduce salt contaminations by repeated handling (alkali salt traces on the pipette tips, etc.), a new portion was used every day. Alternatively, some of the NH 4 + -loaded cation exchange material can be added to the final matrix solution, keeping the solution free of alkali ions over a long time.
Sample preparation for MALDI-MS
Samples were dissolved in ultra pure water to a final concentration of approx. 10 ngl/il. Aliquots of 1 jtl of analyte solution and 2 jtl of matrix solution were mixed on a flat metalic sample support and dried in a stream of cold air. Remaining alkali cations present in the sample solution and on the sample support surface were removed from the sample droplet with NH 4 + -loaded cation exchange polymer beads as reported previously (8) .
RNA manipulations
The 23 nt and 461 nt in vitro transcripts were produced by T7 RNA polymerase (Stratagene, USA) transcription of the plasmids pTZ18R linearized with the restriction enzyme Aval and pH4-Ixx389 (pBluescript-KS + harboring a fragment of the histone H4-I gene from Tetrahymena thermophilia) digested with Xbal, respectively. The 55 and 195 nt in vitro transcripts were made by transcription with T3 RNA polymerase (Promega Biotech, USA) of Hindm and BstNl digested pBluescript-KS +, respectively. The transcription reactions contained 40 mM Tris-HCl (pH 8.4 at room temperature), 20 mM MgCl 2 , 1 mM spermidine, 10 mM NaCl, 10 mM DTT, 1 unit//tl RNAsin (Promega Biotech, USA), 4 mM of each ribonucleoside triphosphate, 50 ng template DNA/jtl and 0.5 unit//tl RNA polymerase. The reactions were incubated at 37°C for 2 hours, EDTA was added to a concentration of 15 mM and the RNA was precipitated with 2 M NH 4 -acetate/2.5 volumes of ethanol and dissolved in water. Unless odierwise stated, the transcripts were treated with 2 units calf intestine phosphatase (CIP) (Boehringer Mannheim, FRG) per /tg template DNA at 37°C for 2 hours and precipitated as above. All transcripts were purified by electrophoresis through a denaturating polyacrylamide gel as described (9) . To 3'-end-label the purified 23 nt transcript, approx. 0. 
ng was 5'-end-labeled with [?-
32 P]-ATP (New England Nuclear, USA) and T4 polynucleotide kinase (Stratagene, USA) as described (13) . End-labeled transcripts were precipitated, redissolved in 90% formamide/10 mM EDTA and analyzed on denaturating polyacrylamide gels (13) .
For 3'-exonuclease digestions, 1 ng of RNA (5'-[ 32 P]-endlabeled for subsequent gel analysis) was incubated in 15 ^1 of 10 mM Tris-HCl (pH 8.9) with 0.3 units of phosphodiesterase from Crotalus durissus (Boehringer Mannheim, FRG) at 37 °C. 1 /tl aliquots were taken out at the time points indicated and mixed either directly with 1.5 iA of 3-HPA.(50 g/1) for MALDI-MS analysis or with 1 /tl of 0.1 M EDTA, dried and dissolved in 90% formamide/10 mM EDTA for denaturating polyacrylamide gel electrophoresis.
RESULTS
Heterogeneity and mass resolution of in vitro transcripts
Transcripts synthesized in vitro by the action of bacteriophage RNA polymerases should, in theory, harbour a 5'-triphosphate group. However, due to the instability of the phosphoanhydride bonds, a significant loss of one or two phosphate groups during purification and sample preparation for MALDI-MS may be expected. Also, transcription initation with a mono-or diphosphate nucleotide (14) (present as an impurity in the nucleoside triphosphate solution) will contribute to a 5'-heterogeneity. A varying number of 5'-phosphate groups cannot be resolved on denaturating polyacrylamide gels but would contribute to the observed low mass resolution of in vitro transcripts (9) . To examine this, a 23 nt in vitro transcript treated with calf intestine phosphatase (CIP) to remove all 5'-phosphate groups was analyzed in parallel with an untreated sample. A sample of this size is within the mass range where the presence of different numbers of phosphate groups can be resolved.
Figure la shows that we indeed observed the loss of one phosphate group from the 5'-end of the transcript (seen on the 23 nt product, only; the 3'-heterogeneity of the 24 nt and 25 nt products discussed below partially obscures the phosphate loss). Thus, a peak broadening to the low mass side will be the consequence when this mass loss (80 Da) cannot be resolved. That the broad peaks are due to the 5'-phosphates is confirmed by the removal of these phosphates (figure lb). The mass resolution is significantly improved and the 23 nt product is represented by one single well-defined peak. We have observed that the dephosphorylated RNA samples are significantly easier to analyse and gives sharper peaks man the phosphorylated. The reason for this phenomenon is not clearly understood but we speculate that the negatively charged triphosphate end may complex with divalent cations, e.g. iron from the sample support, and thereby hamper either the incorporation of the analyte into the matrix crystals or the desorption/ionization process.
In addition to the expected 23 nt transcript, 24 nt and 25 nt products were even more abundant. After treatment with CIP (figure lb), the origin of the 24 and 25 mers was revealed to be a template independent and unspecific elongation of the 23 nt transcript. Any possible nucleotide combination for this elongation, which has previously been reported (15, 16) , was observed. The extensive heterogeneity of this sample was verified by polyacrylamide gel electrophoresis of 3'-end-labeled aliquots, both untreated and CIP treated (figure lc). A second cause of 3'-heterogeneity is premature termination of the transcription reaction. In figure 2a , the template used should give rise to a 55 nucleotide product. However, the main product was a 54-mer and a smaller amount of 55-mers generated mainly by unspecific elongation of the 54-mer as revealed by CIP treatment (figure 2b). Thus, a heterogeneity in the 5'-end caused by a varying number of phosphate groups combined with an extensive 3'-heterogeneity, due to both premature termination and unspecific nucleotide addition, will severely decrease the mass resolution of larger in vitro transcripts because the individual components are difficult to resolve. Since we have previously obtained good signals from a 104 nt transcript with a phosphorylated 5'-end in IR-MALDI-MS (9), we wanted to investigate if UV-MALDI-MS works equally well for larger in vitro transcripts. Figure 3a shows the spectrum of a dephosphorylated in vitro transcript from a 195 base pair (bp) template. An intense but rather broad peak with tailing to the high mass end was observed. Undoubtedly, the 3'-heterogeneity described above is a main cause of this tailing. A denaturating polyacrylamide gel of the sample, labeled radioactively, indeed showed that it appeared as a double band (figure 3b) and upon longer time of autoradiography, additional bands from larger products could be seen (data not shown). Thus, we conclude that given a homogeneous sample, a much higher resolution is obtainable.
A UV-MALDI-MS spectrum of a 150 nt DNA sample has been reported (17) . The mass resolution for this sample was below 10, thus indicating the present upper limit for the analysis of DNA samples. To investigate the upper limit for RNA samples, we wanted to obtain a mass spectrum of a large in vitro transcript. As seen in figure 4 , an RNA sample from a 461 bp template, even with the presumed 3'-heterogeneity, gave rise to a well defined peak with a mass resolution of ca. 30 (FWHM). This is a clear illustration of the much increased stability of RNA samples compared to DNA in MALDI-MS, as previously mentioned.
Exonuclease sequencing of RNA Exonuclease digests on oligodeoxynucleotides of 12 nt have recently been employed to demonstrate sequence determination by MALDI-MS (6). We performed time course 3'-exonuclease degradation of the 54/55 nt in vitro transcript shown in figure  2b and analyzed the products directly by MALDI-MS. The first action of the enzyme on the 55 nt substrate is to remove the 3'-heterogenity, thus generating a product identical with the original 54 nt transcript harbouring a well defined 3'-end. In figure 5a , the result of such an experiment after 1,5, and 20 
37
minutes of digestion is seen. After 1 and 5 minutes, the spectra consist of only four to six major peaks, indicating a fairly uniform degradation of all transcripts. In contrast, a broad distribution, with all possible species from 47 nt down to 4 nt clearly present in the spectrum, was observed after 20 minutes reaction time.
Such a distribution is difficult to explain if a uniform degradation from the 3'-end is assumed. Electrophoresis on a denaturating poly aery lamide gel of a 3'-exonuclease digested, radioactively labeled sample (figure 5b) showed, however, that there was a good correlation between the major peaks in the mass spectra and the most prominent bands in the gel. Certain regions in the RNA appear to attenuate the action of the 3'-exonuclease since bands in the corresponding sizes were more abundant. A major attenuation region is position 46-48 from the 5'-end, identical to the start of the ladder in the spectrum after 20 minutes digestion time. Thus, this region was responible for the accumulation of degradation products from position 47 and downwards. Attenuation also occured at position 35 -37 from the 5'-end (clearly seen after 90 minutes of digestion), which further contributes to the broad distribution of the exonuclease products. The phenomenon that smaller molecular ions are registered with higher signal intensities than bigger ones is a general characteristic of MALDI-MS and especially prominent for DNA-mixture mass spectra (18) . Since the low mass peaks were relatively large compared to the intensities of the corresponding bands in the gel, this phenomenon also appears to affect the peak intensities in the 3'-exonuclease digest spectrum. The fact that the peaks in the M ALDI spectrum of the 20 minutes digestion are superimposed on a decreasing base line (indicated by the broken curve in figure  5a ) also has to be taken into account, when comparing with the signal intensities in the corresponding polyacrylamide gel lane.
3'-deoxynucleotides is performed as 4 independent reactions, one for each type of termination nucleotide, one would only require a resolution where peaks, differing by one nucleotide (more than 300 Da) in mass, can be distinguished. Since the sequencing products would be the result of specific termination nucleotides, on which extension cannot occur, problems with 3'-end heterogeneity would not be encountered. Thus, a more than sufficient mass resolution, comparable to the one in the above exonuclease digests, is to be expected. It should be noted that these considerations are generally not valid for the analysis of DNA.
In addition, mass spectrometry gives an absolute size determination in contrast to polyacrylamide gels, where the size of a sample must be determined relatively to standard markers. Hence, MALDI-MS can be applied directely, without the need for markers, whenever the size (mass) of the RNA product is the desired result of an experiment. Examples are the mapping of transcription start sites by RNase protection (20) and detection of protein interaction sites on ribosomal RNA (21) .
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DISCUSSION
Application of MALDI-MS of RNA in molecular biology
The mass accuracy of this method is sufficiently good to determine the position of adenosine (329.2 Da), guanosine (345.2 Da) and pyrimidine nucleotides in the spectra of the exonuclease digest (figure 5a), as exemplified in table I. However, the mass difference between uridine (306.2 Da) and cytidine (305.2 Da) nucleotides is below the mass accuracy of MALDI-MS 'timeof-flight' instruments in the investigated upper mass range. Thus, exonuclease sequencing of an unknown RNA sample is not possible. However, the technique is well suited for determining the position and possibly the identity of modified nucleotides in RNA samples of biological and synthetic origin. By analyzing time course digests, it should be possible to 'scan' through analytes which are significantly larger than the 55 mer demonstrated here. In the low mass range a mass accuracy, allowing one to distinguish between cytidine and uridine, can be obtained by using a detection mode with a reduced post acceleration voltage (9) . However, such a detection mode is not suited for the analysis of larger nucleic acid molecules.
Because a procedure for sequencing DNA using an RNA polymerase and 3'-deoxynucleotides as chain terminators has been published (19), our results represent an important step towards the use of MALDI-MS in DNA sequencing. On automated sequencers, di-deoxynucleotide termination ('Sanger') sequencing routinely allows determination of approx. 600 nt per reaction. Thus, the upper size limit for MALDI-MS of RNA, which is above the 461 nt we report here, is comparable to the performance of automated sequencers. The amount of sample use for the 195 nt RNA spectrum (figure 3a) was approx. 3 pmoles and spectra could be obtained with 5 times less analyte. Since RNA polymerases generally produce more than one transcript per template, we are approaching a sensitivity, also in the higher mass range, where the products of a DNA sequencing with an RNA polymerase can be detected. Because the sequencing with
